Owners, management and financials
CVR: 41537388
DKK 3,364,006
Gross profit
Net result: DKK 419,568
Obi1 Holding ApS (100%)
CVR · view owners
Lars Holten-Andersen
CVR · view management
Active
Founded 23 July 2020
CVR · view overview
2 employees
CVR · 2026
Owner registered: Obi1 Holding ApS
CVR · 01/01/2022
View the full event history
Copenhagen Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Vanløse, founded in 2020. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Lars Holten-Andersen. The company is owned by Obi1 Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,364,006 and a net result of DKK 419,568 compared with DKK 558,252 the year before. Equity in the 2025 report amounted to DKK 601,867.
Source: annual report 2025, Danish Business Authority
Copenhagen Pharma Consulting ApS demonstrates a positive financial trajectory, with gross profit increasing from 1,304,771 DKK in 2022 to 3,364,006 DKK in 2025, indicating strong growth in profitability. Despite not disclosing revenue figures, the company has successfully transitioned from a loss of 37,796 DKK in 2022 to a profit of 419,568 DKK in 2025, showcasing improved operational efficiency. Equity has fluctuated but remains healthy, decreasing from 1,682,299 DKK in 2024 to 601,867 DKK in 2025, raising concerns about sustainability. Positioned within the broader scientific and technical services industry, the company appears to be carving out a niche, although its employee count remains unknown, limiting insights into its operational scale.
AI-generated summary · Generated 13/08/2026
Virksomhedens formål er at drive konsulentvirksomhed fokuseret på forsknings- og udviklingsopgaver for firmaer indenfor biotek og pharma og hermed forbundet virksomhed
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 3.4M | 420K | 1.5M | 602K | 2 | |
| 202401/01/2024 – 31/12/2024 | 2.6M | 558K | 2.4M | 1.7M | 2 | |
| 202301/01/2023 – 31/12/2023 | 2.9M | 336K | 2.4M | 1.2M | 2 | |
| 202201/01/2022 – 31/12/2022 | 1.3M | -38K | 1.2M | 906K | 2 |
Compared to 1.140 companies in Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of Copenhagen Pharma Consulting ApS is 41537388.
Copenhagen Pharma Consulting ApS is owned by Obi1 Holding ApS.
The management of Copenhagen Pharma Consulting ApS consists of Lars Holten-Andersen.
In 2025, Copenhagen Pharma Consulting ApS reported a gross profit of DKK 3,364,006.
Copenhagen Pharma Consulting ApS had 2 employees in 2026 according to the Danish CVR register.
Copenhagen Pharma Consulting ApS was founded on 23 July 2020.
Claim this page to add your logo and social links. Free to get started.
Copenhagen Pharma Consulting ApS has published its annual report for 2025. Gross profit came to DKK 3,364,006, and the net result was DKK 419,568.
Copenhagen Pharma Consulting ApS has published its annual report for 2024. Gross profit came to DKK 2,617,035, and the net result was DKK 558,252.
Copenhagen Pharma Consulting ApS has published its annual report for 2023. Gross profit came to DKK 2,931,273, and the net result was DKK 335,687.
Copenhagen Pharma Consulting ApS has published its annual report for 2022. Gross profit came to DKK 1,304,771, and the net result was DKK -37,796.
Copenhagen Pharma Consulting ApS has published its interim report for the period July 23, 2020 to December 31, 2021.
As of January 1, 2022, Obi1 Holding ApS is registered as an owner of Copenhagen Pharma Consulting ApS with an ownership share of 100%.
As of July 23, 2020, Lars Holten-Andersen is registered as adm. dir. of Copenhagen Pharma Consulting ApS.
Copenhagen Pharma Consulting ApS was founded on July 23, 2020.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Companies in the same industry and area
CVR 46805739
CVR 46279840
CVR 45726460
CVR 44837102
CVR 28489455
